^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

praluzatamab ravtansine (CX-2009)

i
Other names: CX-2009, CD166 PDC, CD166-targeting probody drug conjugate
Company:
AbbVie, CytomX
Drug class:
Microtubule inhibitor, CD166-targeted antibody-drug conjugate
Related drugs: